Eric Fynn-Thompson

Title: Eric Fynn-Thompson: Innovator in Androgen Treatment

Introduction

Eric Fynn-Thompson is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of conditions characterized by excess androgen levels. His innovative approach has the potential to impact various medical conditions.

Latest Patents

Eric Fynn-Thompson holds a patent for the "Use of Mullerian inhibiting substance for treating excess androgen states." This invention provides a method for treating conditions characterized by an excess of androgens. The method involves administering an effective amount of Mullerian inhibiting substance (MIS) protein or nucleic acid encoding MIS to a patient. Additionally, it offers a way to decrease androgen levels below normal levels, making it particularly beneficial for treating prostatic cancer, polycystic ovarian disease, benign prostatic hypertrophy, and precocious puberty. He has 1 patent to his name.

Career Highlights

Eric is affiliated with The General Hospital Corporation, where he continues to work on innovative medical solutions. His research and inventions are aimed at improving patient outcomes in various androgen-related conditions.

Collaborations

He has collaborated with esteemed colleagues such as Patricia K Donahoe and Jose Teixeira, contributing to a rich environment of innovation and research.

Conclusion

Eric Fynn-Thompson's work in the field of androgen treatment exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new therapeutic approaches that could benefit many patients.